USP订购编号 |
美国药典,USP分析标准品,英文名称,规格 |
CAS编号查询 |
UN编号对照 |
USP-1667280 |
Tiagabine Hydrochloride (300 mg) |
145821-59-6 |
|
2934990005 |
|
|
|
USP-1667290 |
Tiamulin Fumarate (250 mg) |
55297-96-6 |
|
2941906000 |
|
|
|
USP-1667304 |
Ticarcillin Monosodium Monohydrate (350 mg) |
74682-62-5 |
|
2941106000 |
|
|
|
USP-1667315 |
Timolol Related Compound B (20 mg) (3-(tert-Butylamino)-2-(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-1-ol) |
59697-06-2 |
|
2934990005 |
|
|
|
USP-1667326 |
Timolol Related Compound C (20 mg) (N-(tert-Butyl)-2,3-bis(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-1-amine maleate) |
610271-57-3 |
|
2934990005 |
|
|
|
USP-1667337 |
Tiamulin Related Compound A (50 mg) (Tosyl pleuromutilin) |
31716-01-5 |
|
2941906000 |
|
|
|
USP-1667348 |
Timolol Related Compound F (20 mg) (3-Chloro-4-morpholino-1,2,5-thiadiazol) |
30165-96-9 |
|
2934990005 |
|
|
|
USP-1667355 |
Tiamulin (100 mg) |
55297-95-5 |
|
2941906000 |
|
|
|
USP-1667359 |
Tiletamine Hydrochloride (200 mg) |
14176-50-2 |
UN2811 |
USP-1667369 |
Timolol Related Compound D (20 mg) (4-Morpholino-1,2,5-thiadiazol-3-ol) |
30165-97-0 |
|
2934990005 |
|
|
|
USP-1667381 |
Timolol Related Compound A (20 mg) ((R)-1-(tert-Butylamino)-3-(4-morpholino-1,2,5-thiadiazol-3-yloxy)propan-2-ol maleate) |
26839-77-0 |
|
2934990005 |
|
|
|
USP-1667406 |
Timolol Maleate (200 mg) |
26921-17-5 |
|
2934990005 |
|
|
|
USP-1667439 |
Tioconazole (200 mg) |
65899-73-2 |
UN3077 |
USP-1667443 |
Timolol Related Compound E (20 mg) ((S,Z)-4-({1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]propan-2-yl}oxy)-4-oxobut-2-enoic acid maleate salt (1:1)) |
N/A |
|
2934990005 |
|
|
|
USP-1667450 |
Tioconazole Related Compound A (25 mg) (1-[2,4-Dichloro-beta-[(3-thenyl)-oxy]phenethyl]imidazole hydrochloride) |
N/A |
|
2934990005 |
|
|
|
USP-1667461 |
Tioconazole Related Compound B (25 mg) (1-[2,4-Dichloro-beta-[(2,5-dichloro-3-thenyl)oxy]phenethyl]imidazole hydrochloride) |
N/A |
|
2934990005 |
|
|
|
USP-1667472 |
Tioconazole Related Compound C (25 mg) (1-[2,4-Dichloro-beta-[(5-bromo-2-chloro-3-thenyl)-oxy]-phenethyl]imidazole hydrochloride) |
N/A |
|
2934990005 |
|
|
|
USP-1667508 |
Tobramycin (350 mg) |
32986-56-4 |
|
2941901010 |
|
|
|
USP-1667520 |
Tinidazole (200 mg) |
19387-91-8 |
|
2933290000 |
|
|
|
USP-1667530 |
Tinidazole Related Compound A (100 mg) (2-methyl-5-nitroimidazole) |
696-23-1 |
|
2933290000 |
|
|
|
USP-1667541 |
Tinidazole Related Compound B (20 mg) (1-(2-ethyl-sulfonylethyl)-2-methyl-4-nitroimidazole) |
25459-12-5 |
|
2933290000 |
|
|
|
USP-1667574 |
Tiotropium Bromide (100 mg) |
136310-93-5 |
|
2934990005 |
|
|
|
USP-1667585 |
Titanium Dioxide (2 g) |
13463-67-7 |
|
2823000000 |
|
|
|
USP-1667619 |
Tiotropium Related Compound C (25 mg) ((1R,3s,5S)-3-[2-Hydroxy-2,2-di(thiophen-2-yl)acetoxy]-8,8-dimethyl-8-azabicyclo[3.2.1]oct-6-en-8-ium bromide) |
136310-95-7 |
|
2934990005 |
|
|
|
USP-1667621 |
Tiotropium Related Compound G (50 mg) ((1R,2R,4S,5S,7s)-7-Hydroxy-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide) |
1508-46-9 |
|
2933999552 |
|
|
|
USP-1667632 |
Tiotropium Related Compound H (50 mg) ((2RS,3aSR,5RS,6RS,6aRS)-6-Hydroxy-4,4-dimethylhexahydro-2H-2,5-methanofuro[3,2-b]pyrrol-4-ium bromide) |
N/A |
|
2933999552 |
|
|
|
USP-1667665 |
Tigecycline Related Compound B (25 mg) ((4S,4aS,5aR,12aS)-9-Amino-4,7-bis(dimethylamino)-3,10,12,12a-tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2- carboxamide hydrochloride (1:x)) |
N/A |
|
2924296000 |
|
|
|
USP-1667803 |
Alpha Tocopheryl Acid Succinate (250 mg) |
4345/3/3 |
|
2936280000 |
|
|
|
USP-1667905 |
Tizanidine Hydrochloride (200 mg) |
64461-82-1 |
|
2934990005 |
|
|
|
USP-1667916 |
Tizanidine Related Compound A (50 mg) (4-amino-5-chloro-2,1,3-benzothiadiazole) |
30536-19-7 |
|
2934990005 |
|
|
|
USP-1667924 |
Tizanidine Related Compound B (50 mg) (N-acetyltizanidine) |
173532-15-5 |
|
2934990005 |
|
|
|
USP-1667938 |
Tizanidine Related Compound C (50 mg) (1-acetylimidazolidine-2-thione) |
5391-52-6 |
|
2933290000 |
|
|
|
USP-1668001 |
Tolazamide (200 mg) |
1156-19-0 |
|
2935904000 |
|
|
|
USP-1695004 |
Tripelennamine Hydrochloride (200 mg) |
154-69-8 |
|
2933399095 |
|
|
|
USP-1695343 |
Triphenylmethanol (50 mg) |
76-84-6 |
|
2906290000 |
|
|
|
USP-1696007 |
Triprolidine Hydrochloride (300 mg) |
6138-79-0 |
|
2933399095 |
|
|
|
USP-1696109 |
Triprolidine Hydrochloride Z-Isomer (50 mg) |
N/A |
|
2933399095 |
|
|
|
USP-1696153 |
Tritricosanoin (50 mg) |
86850-72-8 |
|
2915900000 |
|
|
|
USP-1696164 |
2,4,6-Tritertbutylphenol (25 mg) (2,4,6-Tri-tert-butylphenol) |
732-26-3 |
UN3077 |
USP-1696175 |
Triuret (300 mg) (Tricarbonodiimidic diamide) |
556-99-0 |
|
2924190002 |
|
|
|
USP-1696200 |
Trisalicylic Acid (100 mg) |
85531-17-5 |
|
2918230000 |
|
|
|
USP-1698002 |
Tromethamine (125 mg) |
77-86-1 |
|
2922199695 |
|
|
|
USP-1699005 |
Tropicamide (200 mg) |
1508-75-4 |
|
2933399095 |
|
|
|
USP-1699027 |
Tropicamide Related Compound B (50 mg) (N-ethyl-2-phenyl-N-(pyridin-4-ylmethyl)acrylamide) |
57322-50-6 |
|
2933399095 |
|
|
|
USP-1699038 |
Tropicamide Related Compound C (25 mg) (3-hydroxy-2-phenylpropionic acid) |
552-63-6 |
|
2918195000 |
|
|
|
USP-1699300 |
Trospium Chloride (100 mg) |
10405-02-4 |
|
2939800000 |
|
|
|
USP-1699322 |
Trospium Chloride Related Compound B (20 mg) ((1R,3r,5S)-8-azabicyclo[3.2.1]octan-3-yl hydroxydiphenylacetate hydrochloride) |
63516-30-3 |
|
2933399095 |
|
|
|
USP-1699333 |
Trospium Chloride Related Compound C (20 mg) ((1R, 3r, 5S)-3-Hydroxyspiro[8-azoniabicyclo[3.2.1]octane-8, 1′-pyrrolidinium]chloride) |
3464-71-9 |
|
2933999552 |
|
|
|
USP-1699956 |
Trypsin Bovine (300 mg) |
9002/7/7 |
|
3507907000 |
|
|
|
USP-1700501 |
L-Tryptophan (200 mg) |
73-22-3 |
|
2933998350 |
|
|
|
USP-1700512 |
Tryptophan Related Compound A (15 mg) ((2S,2’S)-3,3′-[Ethane-1,1-diylbis(1H-indole-1,3-diyl)]bis(2-aminopropanoic acid)) |
132685-02-0 |
|
2933997500 |
|
|
|
USP-1700523 |
Tryptophan Related Compound B (25 mg) (2-Acetamido-3-(1H-indol-3-yl)propanoic acid) |
1218-34-4 |
|
2933998350 |
|
|
|
USP-1500003 |
Paromomycin Sulfate (125 mg) |
1263-89-4 |
|
2941901010 |
|
|
|
USP-1500218 |
Paroxetine Hydrochloride (350 mg) |
110429-35-1 |
UN3077 |
USP-1500230 |
Paroxetine Related Compound B (15 mg) ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-phenylpiperidine hydrochloride) |
N/A |
|
2934990005 |
|
|
|
USP-1500240 |
Paroxetine Related Compound C (30 mg) ((3R,4S)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride) OR ((+)-trans-Paroxetine hydrochloride) |
130855-30-0 |
|
2934990005 |
|
|
|
USP-1500251 |
Paroxetine Related Compound D (10 mg) ((3RS,4RS)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride); cis-paroxetine hydrochloride |
N/A |
|
2934990005 |
|
|
|
USP-1500273 |
Paroxetine Related Compound F (25 mg) ((3S,4R)-3-[(Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-1-methylpiperidine) |
110429-36-2 |
|
2934990005 |
|
|
|
USP-1500284 |
Paroxetine Related Compound G (10 mg) ((+/-)trans-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4”-fluorophenyl-4′-phenyl)piperidine hydrochloride) |
N/A |
|
2934990005 |
|
|
|
USP-1500353 |
Paroxetine System Suitability Mixture A (50 mg) |
N/A |
UN3077 |
USP-1500400 |
Parthenolide (25 mg) |
20554-84-1 |
|
2932206000 |
|
|
|
USP-1500659 |
Pemetrexed Disodium (100 mg) (Disodium N-{p-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-l-glutamate heptahydrate) |
357166-29-1 |
|
2933595960 |
|
|
|
USP-1500808 |
Penbutolol Sulfate (200 mg) |
38363-32-5 |
|
2922190900 |
|
|
|
USP-1501006 |
Penicillamine (200 mg) |
52-67-5 |
|
2930904915 |
|
|
|
USP-1501108 |
Penicillamine Disulfide (200 mg) (3,3′-Dithiodi-D-valine) |
20902-45-8 |
|
2930904915 |
|
|
|
USP-1502009 |
Penicillin G Benzathine (200 mg) |
41372-02-5 |
|
2941102000 |
|
|
|
USP-1502508 |
Penicillin G Potassium (200 mg) |
113-98-4 |
|
2941102000 |
|
|
|
USP-1502552 |
Penicillin G Procaine (200 mg) |
6130-64-9 |
|
2941102000 |
|
|
|
USP-1502701 |
Penicillin G Sodium (150 mg) |
69-57-8 |
|
2941102000 |
|
|
|
USP-1504489 |
Penicillin V (200 mg) |
1987/8/1 |
|
2941106000 |
|
|
|
USP-1504503 |
Penicillin V Potassium (200 mg) |
132-98-9 |
|
2941106000 |
|
|
|
USP-1504900 |
Pentamidine Isethionate (200 mg) |
140-64-7 |
|
2925294500 |
|
|
|
USP-1505506 |
Pentetic Acid (100 mg) |
67-43-6 |
|
2922498050 |
|
|
|
USP-1508901 |
Pentoxifylline (200 mg) |
6493/5/6 |
|
2939590000 |
|
|
|
USP-1558003 |
Prednisolone Tebutate (200 mg) |
7681-14-3 |
|
2937290000 |
|
|
|
USP-1559006 |
Prednisone (250 mg) |
1953/3/2 |
|
2937210000 |
|
|
|
USP-1559629 |
Pregabalin Related Compound A (25 mg) ((R)-3-(Aminomethyl)-5-methylhexanoic acid) |
148553-51-9 |
|
2922493800 |
|
|
|
USP-1559647 |
Pregabalin Related Compound C (25 mg) (需冷链运输) (4-Isobutylpyrrolidin-2-one) |
61312-87-6 |
|
2933790002 |
|
|
|
USP-1560990 |
Prilocaine (200 mg) (需冷链运输) |
721-50-6 |
|
2924296000 |
|
|
|
USP-1561008 |
Prilocaine Hydrochloride (200 mg) |
1786-81-8 |
|
2924296000 |
|
|
|
USP-1561019 |
Prilocaine Related Compound A (100 mg) (o-toluidine hydrochloride) |
636-21-5 |
UN3451 |
USP-1561020 |
Prilocaine Related Compound B (50 mg) ((RS)-N-(4-methylphenyl)-2-(propylamino)propanamide) |
744961-76-0 |
|
2924296000 |
|
|
|
USP-1561507 |
Primaquine Phosphate (200 mg) |
63-45-6 |
UN1544 |
USP-1561518 |
Primaquine Related Compound A (15 mg) (8-[(4-Aminopentyl)amino]-6-methoxyquinoline) |
525-61-1 |
UN1544 |
USP-1562000 |
Primidone (200 mg) |
125-33-7 |
|
2933595960 |
|
|
|
USP-1562011 |
Primidone Related Compound A (20 mg) (2-Ethyl-2-phenylmalonamide) |
7206-76-0 |
|
2924296000 |
|
|
|
USP-1562033 |
Primidone Related Compound C (20 mg) (2-phenyl butyramide) |
90-26-6 |
|
2924296000 |
|
|
|
USP-1563003 |
Probenecid (200 mg) |
57-66-9 |
|
2935904000 |
|
|
|
USP-1563309 |
Probucol (200 mg) |
23288-49-5 |
|
2930902000 |
|
|
|
USP-1563320 |
Probucol Related Compound A (25 mg) (2,2′,6,6′-tetra-tert-butyldiphenoquinone) |
2455-14-3 |
|
2914699000 |
|
|
|
USP-1563331 |
Probucol Related Compound B (25 mg) (4,4′-dithio-bis(2,6-di-tert-butylphenol)) |
N/A |
|
2930902000 |
|
|
|
USP-1563342 |
Probucol Related Compound C (25 mg) (4-[(3,5-di-tert-butyl-2-hydroxyphenylthio)isopropylidenethio]-2,6-di-tert-butylphenol) |
1391054-68-4 |
|
2930902000 |
|
|
|
USP-1563502 |
Procainamide Hydrochloride (200 mg) |
614-39-1 |
|
2924296000 |
|
|
|
USP-1564006 |
Procaine Hydrochloride (200 mg) |
1951/5/8 |
UN2811 |
USP-1565009 |
Procarbazine Hydrochloride (200 mg) |
366-70-1 |
|
2928002500 |
|
|
|
USP-1565010 |
Procarbazine Related Compound A (50 mg) (4-Formyl-N-isopropylbenzamide) |
13255-50-0 |
|
2924296000 |
|
|
|
USP-1566001 |
Prochlorperazine Maleate (200 mg) |
1984/2/6 |
|
2934302300 |
|
|
|
USP-1566045 |
Prochlorperazine Related Compound A (10 mg) (4-Chloro-10-[3-(4-methylpiperazin-1-yl)propyl]-10H-phenothiazine dihydrochloride) |
N/A |
|
2934305050 |
|
|
|
USP-1586009 |
Pyridostigmine Bromide (200 mg) |
101-26-8 |
UN2811 |
USP-1586031 |
Pyridostigmine Related Compound B (10 mg) (3-Hydroxy-1-methylpyridin-1-ium bromide) |
31034-86-3 |
|
2933399095 |
|
|
|
USP-1587001 |
Pyridoxine Hydrochloride (200 mg) |
58-56-0 |
|
2936250000 |
|
|
|
USP-1588004 |
Pyrilamine Maleate (200 mg) |
59-33-6 |
|
2933399095 |
|
|
|
USP-1589007 |
Pyrimethamine (200 mg) |
58-14-0 |
UN2811 |
USP-1604632 |
Risedronate Related Compound B (20 mg) ([3,6-bis[(3-pyridinyl)methyl]-2,5-dihydroxy-2,5-dioxido-1,4,2,5-dioxadiphosphorinane-3,6-diyl]bis[phosphonic acid] disodium tetrahydrate salt) |
N/A |
|
2933399095 |
|
|
|
USP-1604643 |
Risedronate Related Compound C (20 mg) ([2-(3-pyridinyl)ethylidene-1,1]bis(phosphonic acid)) |
75755-10-1 |
|
2933399095 |
|
|
|
USP-1604654 |
Risperidone (100 mg) |
106266-06-2 |
UN2811 |
USP-1604665 |
Risperidone System Suitability Mixture (10 mg) |
N/A |
UN2811 |
USP-1604676 |
Risperidone Related Compounds Mixture (25 mg) |
N/A |
UN2811 |
USP-1604701 |
Ritodrine Hydrochloride (200 mg) |
23239-51-2 |
|
2922504500 |
|
|
|
USP-1604756 |
Risperidone Related Compound G (25 mg) (3-{2-[4-(4-Fluoro-2-hydroxybenzoyl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one hydrochloride) |
152542-00-2 |
|
2934990005 |
|
|
|
USP-1134346 |
Ciprofloxacin Related Compound A (25 mg) (7-Chloro-1-cyclopropyl-4-oxo-6-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid hydrochloride salt) |
N/A |
|
2933599550 |
|
|
|
USP-1134357 |
Cisplatin (100 mg) |
15663-27-1 |
UN3288 |
USP-1134368 |
Citric Acid (200 mg) |
77-92-9 |
|
2918140000 |
|
|
|
USP-1134379 |
Clarithromycin (100 mg) |
81103-11-9 |
|
2941500000 |
|
|
|
USP-1134380 |
Clarithromycin Related Compound A (25 mg) (6,11-di-O-methylerythromycin A) |
81103-14-2 |
|
2932206000 |
|
|
|
USP-1134390 |
Clarithromycin Identity (10 mg) |
81103-11-9 |
|
2941500000 |
|
|
|
USP-1134404 |
Clavam-2-carboxylate Potassium (2 mg) |
2196185-67-6 |
|
3822190000 |
|
|
|
USP-1134426 |
Clavulanate Lithium (200 mg) |
N/A |
|
2934990005 |
|
|
|
USP-1134459 |
Ciprofloxacin Formamide (25 mg) |
93594-39-9 |
|
2933599550 |
|
|
|
USP-1134506 |
Clemastine Fumarate (250 mg) |
14976-57-9 |
UN3077 |
USP-1134619 |
Clarithromycin Impurity D (10 mg) (N-desmethyl clarithromycin) |
101666-68-6 |
|
2932206000 |
|
|
|
USP-1134620 |
Clarithromycin Impurity H (10 mg) (3″-N-Demethyl-3″-N-formyl-6-O-methylerythromycin A) |
127140-69-6 |
|
2932206000 |
|
|
|
USP-1134631 |
Clarithromycin Impurity Q (10 mg) (Clarithromycin N-oxide) |
118074-07-0 |
|
2932206000 |
|
|
|
USP-1134642 |
Clarithromycin Impurity R (10 mg) (3″-N-Demethylerythromycin A) |
992-62-1 |
|
2932206000 |
|
|
|
USP-1134674 |
Clenbuterol Hydrochloride (100 mg) |
21898-19-1 |
UN2811 |
USP-1134696 |
Clenbuterol Related Compound B (10 mg) (1-(4-amino-3,5-dichlorophenyl)-2-tert-butylaminoethanone hydrochloride) |
37148-49-5 |
|
2922390000 |
|
|
|
USP-1135000 |
Clidinium Bromide (500 mg) |
3485-62-9 |
|
2933399095 |
|
|
|
USP-1135021 |
Clidinium Bromide Related Compound A (250 mg) (3-Hydroxy-1-methylquinuclindinium Bromide) |
2096336-00-2 |
|
2933399095 |
|
|
|
USP-1135123 |
Citicoline (30 mg) |
987-78-0 |
|
2934990005 |
|
|
|
USP-1135190 |
Citrus Maxima Peel Flavonoids Dry Extract (500 mg) |
N/A |
|
1302190200 |
|
|
|
USP-1135600 |
Climbazole (400 mg) |
38083-17-9 |
|
2933290000 |
|
|
|
USP-1135892 |
Clindamycin 2,3-Dipalmitate (25 mg) (Methyl 7-chloro-6,7,8-trideoxy-6-(1-methyl-trans-4-propyl-L-2-pyrrolidinecarboxamido)-1-thio-L-threo-alpha-D-galacto-octopyranoside 2,3-dipalmitate monohydrochloride) |
NA |
|
2934990005 |
|
|
|
USP-1136002 |
Clindamycin Hydrochloride (200 mg) |
58207-19-5 |
|
2941906000 |
|
|
|
USP-1137005 |
Clindamycin Palmitate Hydrochloride (500 mg) |
25507-04-4 |
|
2941906000 |
|
|
|
USP-1138008 |
Clindamycin Phosphate (250 mg) |
24729-96-2 |
|
2941906000 |
|
|
|
USP-1138019 |
Clindamycin Phosphate System Suitability (30 mg) |
24729-96-2 |
|
2933999552 |
|
|
|
USP-1138201 |
Clioquinol (500 mg) |
130-26-7 |
|
2933492250 |
|
|
|
USP-1138314 |
Clobazam Related Compound A (25 mg) (8-Chloro-1-phenyl-1,5-dihydro-2H-benzo[b][1,4]diazepine-2,4(3H)-dione) |
22316-55-8 |
|
2933790002 |
|
|
|
USP-1138405 |
Clobetasol Propionate (200 mg) |
25122-46-7 |
|
2937220000 |
|
|
|
USP-1138427 |
Clobetasol Propionate Related Compound A (50 mg) (9-alpha-fluoro-11-beta-hydroxy-16-beta-methyl-3-oxoandrosta-1,4-diene-17(R)-spiro-2′-[4′-chloro-5′-ethylfuran-3′(2’H)-one]) |
N/A |
|
2932190002 |
|
|
|
USP-1138493 |
Clocortolone (25 mg) (9-Chloro-6alpha-fluoro-11beta,21-dihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione) |
4828-27-7 |
|
2937220000 |
|
|
|
USP-1138507 |
Clocortolone Pivalate (200 mg) |
34097-16-0 |
|
2937220000 |
|
|
|
USP-1138904 |
Clofazimine (200 mg) |
2030-63-9 |
|
2933994600 |
|
|
|
USP-1138926 |
Clofazimine Related Compound B (25 mg) (5-(4-Chlorophenyl)-3-(isopropylimino)-N-phenyl-3,5-dihydrophenazin-2-amine) |
2158184-11-1 |
|
2933998350 |
|
|
|
USP-1140101 |
Clomiphene Related Compound A (100 mg) ((E,Z)-2-[4-(1,2-Diphenylethenyl)phenoxy]-N,N-diethylethanamine hydrochloride (1:1)) |
N/A |
|
2922199695 |
|
|
|
USP-1140247 |
Clomipramine Hydrochloride (200 mg) |
17321-77-6 |
UN3077 |
USP-1140258 |
Clomipramine Related Compound A (25 mg) (N1-[3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]-N1,N3,N3-trimethylpropane-1,3-diamine dihydrochloride) |
2305824-51-3 |
|
2933998350 |
|
|
|
USP-1140269 |
Clomipramine Related Compound C (15 mg) (3-(3-Chloro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride, monohydrate) |
N/A |
|
2933997500 |
|
|
|
USP-1140270 |
Clomipramine Related Compound D (15 mg) (3-(3,7-Dichloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine hydrochloride) |
115189-28-1 |
|
2933997500 |
|
|
|
USP-1140292 |
Clomipramine Related Compound F (15 mg) (3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepine) |
32943-25-2 |
|
2933997500 |
|
|
|
USP-1140327 |
Clonazepam Related Compound A (25 mg) (3-Amino-4-(2-chlorophenyl)-6-nitrocarbostyril) |
55198-89-5 |
|
2933790002 |
|
|
|
USP-1140338 |
Clonazepam Related Compound B (25 mg) (2-Amino-2′-chloro-5-nitrobenzophenone) |
2011-66-7 |
|
2922390000 |
|
|
|
USP-1140349 |
Clonazepam Related Compound C (25 mg) (2-bromo-2′-(2-chlorobenzoyl)-4′-nitroacetanilide) |
52130-87-7 |
|
2924296000 |
|
|
|
USP-1140393 |
Clonidine (200 mg) |
4205-90-7 |
UN2811 |
USP-1140407 |
Clonidine Hydrochloride (200 mg) |
4205-91-8 |
UN2811 |
USP-1140418 |
Clonidine Related Compound A (25 mg) (1-Acetyl-2-(2,6-dichlorophenylimino)-imidazolidine) |
54707-71-0 |
|
2933290000 |
|
|
|
USP-1140429 |
Clonidine Related Compound B (25 mg) (2-[(E)-2,6-dichlorophenylimino]-1-(1-{2-[(E)-2,6-dichlorophenylimino]-imidazolidin-1-yl}-ethyl)-imidazolidine) |
N/A |
UN2811 |
USP-1140430 |
Clopidogrel Bisulfate (125 mg) |
120202-66-6 |
UN3261 |
USP-1140445 |
Clonidine Related Compound C (15 mg) (Methyl N’-(2,6-dichlorophenyl)carbamimidothioate) |
27806-81-1 |
|
2930902000 |
|
|
|
USP-1140586 |
Clopidogrel Related Compound A (20 mg) ((+)-(S)-(o-chlorophenyl)-6,7-dihydrothieno[3,2-c]pyridine-5(4H)-acetic acid, hydrochloride) |
144750-42-5 |
|
2934990005 |
|
|
|